Skip to main content

Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition

Publication ,  Journal Article
Richman, B; Schulman, W
Published in: Loyola University Chicago Law Review
2017

Duke Scholars

Published In

Loyola University Chicago Law Review

Publication Date

2017

Volume

48

Start / End Page

787 / 819
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Richman, B., & Schulman, W. (2017). Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition. Loyola University Chicago Law Review, 48, 787–819.
Richman, B., and W. Schulman. “Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition.” Loyola University Chicago Law Review 48 (2017): 787–819.
Richman B, Schulman W. Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition. Loyola University Chicago Law Review. 2017;48:787–819.
Richman, B., and W. Schulman. “Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition.” Loyola University Chicago Law Review, vol. 48, 2017, pp. 787–819.
Richman B, Schulman W. Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition. Loyola University Chicago Law Review. 2017;48:787–819.

Published In

Loyola University Chicago Law Review

Publication Date

2017

Volume

48

Start / End Page

787 / 819